Literature DB >> 17211195

Repetitive ischemia-reperfusion injury: a plausible mechanism for documented clinical burn-depth progression after thermal injury.

Amin D Jaskille1, James C Jeng, Julio C Sokolich, Patricia Lunsford, Marion H Jordan.   

Abstract

Our previous studies confirmed the phenomenon of burn depth progression despite adequate Parkland formula resuscitation [Kim et al. J Burn Care Rehabil 2001;22960:406-6]. Repetitive ischemia-reperfusion injury (I-R) is a plausible explanation and is suggested by the concomitant swings we have observed in serum base deficit (BD) during resuscitation from burn shock. We chose to explore whether laser Doppler imaging (LDI) evidence of burn depth progression mirrored cycles of I-R (episodic swings in continuously measured BD). Positive findings would support the hypothesis that repetitive episodes of I-R is a factor in burn depth progression despite apparently adequate resuscitation. A total of 14 patients with severe life-threatening burns (median 51% TBSA) underwent continuous BD monitoring using a Paratrend 7 (Malvern PA) during 48 hours of resuscitation. Fluid needs were estimated using the Parkland formula, then were titrated to urine output. The slopes of BD changes were then analyzed. Worsening of BD greater than 0.2 mmol/l/min was noted, and a proportion derived relative to pooled data on 5-minute intervals. In four of the patients, LDI scans were performed on six representative areas sequentially every 4 hours. The analysis of median flux in these LDI images provided real-time determination of burn depth progression. Eight patients eventually died. Only four patients achieved a normal BD within 12 hours of monitoring despite exceeding the Parkland formula estimate and meeting urinary output parameters. Our analysis also showed cyclical peaks and valleys in the BD curve (P < .001), suggesting repetitive I-R insults. All increases in BD preceded changes that could be detected in vital signs or urine output. Finally, LDI confirmed that the burn depths continued to progress despite apparently adequate resuscitation, and also showed that there are similar peaks and valleys in the perfusion of the wounds (P < .0001), which mimic the changes in the BD curve. Responses to fluid resuscitation do not follow a linear pattern in the case of massive burns. These results in repetitive periods of tissue hypoperfusion evidenced by BD alterations and may contribute to progressive deepening of the burn wound.

Entities:  

Mesh:

Year:  2007        PMID: 17211195     DOI: 10.1097/BCR.0b013E31802CB82C

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  6 in total

1.  Vasoactive effect of fibronectin-derived epiviosamine-1 and related peptides in quiescent and stress models.

Authors:  Mary D Frame; Fubao Lin; Anthony M Dewar; Richard A F Clark
Journal:  Microcirculation       Date:  2017-08       Impact factor: 2.628

Review 2.  Toll-Like Receptor Signaling in Burn Wound Healing and Scarring.

Authors:  Peter D'Arpa; Kai P Leung
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

3.  Regulation of Key Immune-Related Genes in the Heart Following Burn Injury.

Authors:  Jake J Wen; Keyan Mobli; Geetha L Radhakrishnan; Ravi S Radhakrishnan
Journal:  J Pers Med       Date:  2022-06-20

4.  Mannose-binding lectin (MBL) and the lectin complement pathway play a role in cutaneous ischemia and reperfusion injury.

Authors:  Claas-Tido Peck; Sarah Strauß; Gregory L Stahl; Peter-Maria Vogt; Marc N Busche
Journal:  Innov Surg Sci       Date:  2020-09-14

Review 5.  The evaluation and management of thermal injuries: 2014 update.

Authors:  Jimmy Toussaint; Adam J Singer
Journal:  Clin Exp Emerg Med       Date:  2014-09-30

6.  An objective measure for the assessment and management of fluid shifts in acute major burns.

Authors:  Pippa Kenworthy; Michael Phillips; Tiffany L Grisbrook; William Gibson; Fiona M Wood; Dale W Edgar
Journal:  Burns Trauma       Date:  2018-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.